Literature DB >> 20573484

A simple method for calculating power based on a prior trial.

George F Borm1, Bastiaan R Bloem, Marten Munneke, Steven Teerenstra.   

Abstract

OBJECTIVE: When an investigator wants to base the power of a planned clinical trial on the outcome of another trial, the latter study may not have been reported in sufficient detail to allow this. For example, when the outcome is a change from baseline, the power calculation requires the standard deviation of the difference, and it frequently happens that only the standard deviations of the baseline and the follow-up measurements are reported. Also when a complex analysis or an analysis with covariates is planned, the power calculation may be difficult or impossible. The objective was to develop a method to determine the power of a trial, based on minimal information from a previous (reference) trial. STUDY DESIGN AND
SETTING: We investigated the power calculation for a range of statistical methods, including the t-test, analysis of covariance, analysis of variance, linear regression, logistic regression, Poisson regression, the Wilcoxon test, and the logrank test.
RESULTS: A method to calculate the power of a trial solely based on the P-value or the confidence interval of the outcome of the reference study.
CONCLUSION: A power calculation based on an earlier similar trial only requires its P-value.

Mesh:

Year:  2010        PMID: 20573484     DOI: 10.1016/j.jclinepi.2009.10.011

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  2 in total

1.  A simulation-based sample size calculation method for pre-clinical tumor xenograft experiments.

Authors:  Jianrong Wu; Shengping Yang
Journal:  J Biopharm Stat       Date:  2017-04-27       Impact factor: 1.051

2.  Time between diagnosis and surgical treatment on pathological and clinical outcomes in prostate cancer: does it matter?

Authors:  Mariana Andozia Morini; Roberto Lodeiro Muller; Paulo César Barbosa de Castro Junior; Rafael José de Souza; Eliney Ferreira Faria
Journal:  World J Urol       Date:  2018-03-16       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.